Correction to “In silico simulation of inhibitor drug effects on nuclear factor--κB pathway dynamics”

doi:10.1016/s0026-895x(24)05661-x

JOURNAL ARTICLE

Correction to “In silico simulation of inhibitor drug effects on nuclear factor--κB pathway dynamics”

Year: 2004 Journal: Molecular Pharmacology Vol: 66 (3)Pages: 770-770 Publisher: American Society for Pharmacology and Experimental Therapeutics

DOI: 10.1016/s0026-895x(24)05661-x

Get Full-Text PDF Get Analytical Report

Keywords:

In silico Dynamics (music) Computer science Drug Computational biology Pharmacology Chemistry Psychology Biology Biochemistry

Metrics

Cited By

0.00

FWCI (Field Weighted Citation Impact)

Refs

0.42

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Topics

Cytokine Signaling Pathways and Interactions

Health Sciences → Medicine → Oncology

Melanoma and MAPK Pathways

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

NF-κB Signaling Pathways

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

Correction to “In silico simulation of inhibitor drug effects on nuclear factor--κB pathway dynamics”

Metrics

Topics

Related Documents

In Silico Simulation of Inhibitor Drug Effects on Nuclear Factor-κB Pathway Dynamics

Correction to "In silico simulation of inhibitor drug effects on nuclear factor-- B pathway dynamics"

Computational Drug Discovery Approach Based on Nuclear Factor-κB Pathway Dynamics

Exogenous ghrelin ameliorates acute lung injury by modulating the nuclear factor κB inhibitor kinase/nuclear factor κB inhibitor/nuclear factor κB pathway after hemorrhagic shock

Interrogation of Inhibitor of Nuclear Factor κB α/Nuclear Factor κB (IκBα/NF-κB) Negative Feedback Loop Dynamics